The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes
- PMID: 21473863
- DOI: 10.1016/j.ejphar.2011.03.035
The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes
Abstract
We have previously shown that 5-HT(1B) receptors inhibit prejunctionally the rat vasodepressor CGRPergic sensory outflow. Since 5-HT(1) receptors comprise 5-HT(1A), 5-HT(1B), 5-HT(1D) and 5-HT(1F) functional subtypes, this study has further investigated the role of 5-HT(1A), 5-HT(1D) and 5-HT(1F) receptor subtypes in the inhibition of the above vasodepressor sensory outflow. Pithed rats were pretreated with i.v. continuous infusions of hexamethonium and methoxamine, followed by 5-HT(1) receptor agonists. Then electrical spinal stimulation (T(9)-T(12)) or i.v. bolus injections of exogenous α-CGRP produced frequency-dependent or dose-dependent vasodepressor responses. The electrically-induced vasodepressor responses remained unchanged during infusions of the 5-HT(1A) receptor agonists 8-OH-DPAT and NN-DP-5-CT. In contrast, these responses were inhibited by the agonists sumatriptan (5-HT(1A/1B/1D/1F)), indorenate (5-HT(1A)), PNU-142633 (5-HT(1D)) or LY344864 (5-HT(1F)), which did not affect the vasodepressor responses to exogenous CGRP (implying a prejunctional sensory-inhibition). When analysing the effects of antagonists: (i) 310 μg/kg (but not 100 μg/kg) GR127935 (5-HT(1A/1B/1D/1F)) abolished the inhibition to sumatriptan, indorenate, PNU-142633 or LY344864; (ii) 310 μg/kg SB224289 (5-HT(1B)) or BRL15572 (5-HT(1D)) failed to block the inhibition to sumatriptan or PNU-142633, whereas SB224289+BRL15572 partly blocked the inhibition to sumatriptan; and (iii) 10 μg/kg WAY100635 (5-HT(1A)) failed to block the inhibition to indorenate. These results suggest that 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), receptor subtypes inhibit the vasodepressor sensory CGRPergic outflow although, admittedly, no selective 5-HT(1F) receptor agonist is available yet. The pharmacological profile of these receptors resembles that shown in rat dorsal root ganglia by molecular biology techniques.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α2-adrenoceptors and 5-HT1 receptors.J Headache Pain. 2018 May 25;19(1):40. doi: 10.1186/s10194-018-0869-8. J Headache Pain. 2018. PMID: 29802544 Free PMC article.
-
Activation of 5-HT1B receptors inhibits the vasodepressor sensory CGRPergic outflow in pithed rats.Eur J Pharmacol. 2010 Jul 10;637(1-3):131-7. doi: 10.1016/j.ejphar.2010.03.053. Epub 2010 Apr 10. Eur J Pharmacol. 2010. PMID: 20385119
-
The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1A, 5-HT1B and 5-HT1D subtypes.Br J Pharmacol. 1998 Jul;124(5):1001-11. doi: 10.1038/sj.bjp.0701907. Br J Pharmacol. 1998. PMID: 9692787 Free PMC article.
-
[Role of serotonin receptors in vascular tone in the pithed rat].Arch Cardiol Mex. 2009 Dec;79 Suppl 2:83-94. Arch Cardiol Mex. 2009. PMID: 20361490 Review. Spanish.
-
5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.Eur J Pharmacol. 2005 Dec 5;526(1-3):125-39. doi: 10.1016/j.ejphar.2005.09.065. Epub 2005 Nov 28. Eur J Pharmacol. 2005. PMID: 16310183 Review.
Cited by
-
Olcegepant blocks neurogenic and non-neurogenic CGRPergic vasodepressor responses and facilitates noradrenergic vasopressor responses in pithed rats.Br J Pharmacol. 2017 Jul;174(13):2001-2014. doi: 10.1111/bph.13799. Epub 2017 May 2. Br J Pharmacol. 2017. PMID: 28369749 Free PMC article.
-
Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α2-adrenoceptors and 5-HT1 receptors.J Headache Pain. 2018 May 25;19(1):40. doi: 10.1186/s10194-018-0869-8. J Headache Pain. 2018. PMID: 29802544 Free PMC article.
-
Heteroreceptors Modulating CGRP Release at Neurovascular Junction: Potential Therapeutic Implications on Some Vascular-Related Diseases.Biomed Res Int. 2016;2016:2056786. doi: 10.1155/2016/2056786. Epub 2016 Dec 27. Biomed Res Int. 2016. PMID: 28116293 Free PMC article. Review.
-
Monoaminergic Receptors as Modulators of the Perivascular Sympathetic and Sensory CGRPergic Outflows.Curr Neuropharmacol. 2020;18(9):790-808. doi: 10.2174/1570159X18666200503223240. Curr Neuropharmacol. 2020. PMID: 32364079 Free PMC article. Review.
-
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.Pharmacol Rev. 2021 Jan;73(1):310-520. doi: 10.1124/pr.118.015552. Pharmacol Rev. 2021. PMID: 33370241 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials